Brady (BRC)
(Real Time Quote from BATS)
$60.05 USD
+0.05 (0.08%)
Updated Apr 26, 2024 01:20 PM ET
3-Hold of 5 3
C Value C Growth D Momentum C VGM
Income Statements
Fiscal Year end for Brady Corporation falls in the month of July .
All items in Millions except EPS data.
7/31/23 | 7/31/22 | 7/31/21 | 7/31/20 | 7/31/19 | |
---|---|---|---|---|---|
Sales | 1,332 | 1,302 | 1,145 | 1,081 | 1,161 |
Cost Of Goods | 675 | 671 | 583 | 553 | 582 |
Gross Profit | 657 | 632 | 561 | 529 | 579 |
Selling & Adminstrative & Depr. & Amort Expenses | 432 | 439 | 394 | 391 | 416 |
Income After Depreciation & Amortization | 225 | 193 | 167 | 138 | 162 |
Non-Operating Income | 4 | 0 | 4 | 5 | 5 |
Interest Expense | 4 | 1 | 0 | 2 | 3 |
Pretax Income | 226 | 192 | 171 | 141 | 165 |
Income Taxes | 51 | 42 | 36 | 28 | 33 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | -6 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 175 | 150 | 130 | 112 | 131 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 175 | 150 | 130 | 112 | 131 |
Depreciation Footnote | 7/31/23 | 7/31/22 | 7/31/21 | 7/31/20 | 7/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 258 | 227 | 193 | 161 | 186 |
Depreciation & Amortization (Cash Flow) | 32 | 34 | 25 | 23 | 24 |
Income After Depreciation & Amortization | 225 | 193 | 167 | 138 | 162 |
Earnings Per Share Data | 7/31/23 | 7/31/22 | 7/31/21 | 7/31/20 | 7/31/19 |
---|---|---|---|---|---|
Average Shares | 49.87 | 51.65 | 52.41 | 53.23 | 53.32 |
Diluted EPS Before Non-Recurring Items | 3.64 | 3.15 | 2.65 | 2.11 | 2.46 |
Diluted Net EPS (GAAP) | 3.49 | 2.89 | 2.46 | 2.10 | 2.45 |
Fiscal Year end for Brady Corporation falls in the month of July .
All items in Millions except EPS data.
1/31/24 | 10/31/23 | 7/31/23 | 4/30/23 | 1/31/23 | |
---|---|---|---|---|---|
Sales | 322.62 | 331.98 | 345.93 | 337.12 | 326.25 |
Cost Of Goods | 160.54 | 160.26 | 170.05 | 167.43 | 169.81 |
Gross Profit | 162.08 | 171.72 | 175.88 | 169.69 | 156.44 |
SG&A, R&D, and Dept/Amort Expenses | 108.16 | 111.99 | 113.83 | 106.70 | 107.66 |
Income After SG&A, R&D, and Dept/Amort Expenses | 53.92 | 59.73 | 62.05 | 62.99 | 48.78 |
Non-Operating Income | 2.68 | 0.44 | 2.43 | 0.79 | 0.97 |
Interest Expense | 0.79 | 0.77 | 0.65 | 0.75 | 1.24 |
Pretax Income | 55.82 | 59.40 | 63.82 | 63.03 | 48.51 |
Income Taxes | 12.19 | 12.16 | 14.44 | 14.98 | 10.52 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 43.63 | 47.24 | 49.38 | 48.05 | 37.99 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 43.63 | 47.24 | 49.38 | 48.05 | 37.99 |
Earnings Per Share Data | 1/31/24 | 10/31/23 | 7/31/23 | 4/30/23 | 1/31/23 |
---|---|---|---|---|---|
Average Shares | 48.73 | 48.81 | 49.38 | 50.00 | 50.01 |
Diluted EPS Before Non-Recurring Items | 0.93 | 1.00 | 1.04 | 0.95 | 0.81 |
Diluted Net EPS (GAAP) | 0.90 | 0.95 | 1.00 | 0.96 | 0.76 |